Real-time enrollment status for this carcinoma, renal cell clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:47 AM UTC
| NCT Number | NCT07227415 |
| Recruiting Status | Recruiting |
| Condition | Carcinoma, Renal Cell |
| Phase | PHASE1 |
| Target Enrollment | 224 participants |
| Active Locations | 109 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of August 28, 2026: Clinical trial NCT07227415 is currently recruiting participants. This phase1 study for carcinoma, renal cell is actively seeking new participants at 109 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227415 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 109 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227415 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.